Treace James T's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Mar 2, 2023
- Accession no.
- 0001209191-23-015075
- Filed
- Mar 2, 2023
- Trade date
- Feb 28-Mar 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.07M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Treace James TCIK 0001185191 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Common Stock | SSaleDisposed | −37,316 | $21.54 | −$803,786.64 | 974,125 | Direct | |
| Mar 1, 2023 | Common Stock | SSaleDisposed | −12,684 | $21.36 | −$270,930.24 | 961,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.